openPR Logo
Press release

Viral Conjunctivitis Pipeline Drugs Market to Witness a Healthy Y-o-Y Growth during 2023

03-06-2018 04:02 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Viral Conjunctivitis Pipeline Drugs Market to Witness

Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely to exhibit a thumping CAGR of 69.60% between 2020 and 2023 and reach an opportunity worth US$462.4 mn by the end of the forecast period.

Get Sample of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12251

The increasing investments from ophthalmic drug manufacturers for the development of efficient treatment for viral conjunctivitis, coupled with the increasing awareness among people and augmenting expenditure on healthcare, are accelerating the growth rate of this market significantly.

On the other hand, lower diagnosis rate of viral conjunctivitis is decreasing the patient pool for the treatment, causing major hindrance in the market’s growth.

Pipeline Drugs in U.S. Gain Momentum from Promising Results of Ongoing Clinical Trials

The U.K., the U.S., Germany, Australia, Japan, and Brazil are the key regional markets for viral conjunctivitis pipeline drugs. Considering the ongoing clinical trials, the U.S. is likely to occupy the leading position among these in the coming years. The major factors driving the growth in this market are promising results of the ongoing clinical trials, the increasing awareness regarding eye care among patients and medical professionals, the high cost of the drugs, and the availability of viral conjunctivitis diagnostic tests.

The U.S. market for viral conjunctivitis pipeline drugs is projected to report a CAGR of 46.50% during the period from 2020 to 2023.

Get Brochure of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12251

APD-209 to Exceed FST-100 by 2023

APD-209 and FST-100 are the main viral conjunctivitis drugs in the pipeline. Among the two, FST-100 is projected to hold the largest share in the market by 2020. Foresight Biotherapeutics Inc. initiated the development of FST-100; however, the company was acquired by Shire Plc. in the midway. In May 2014, the drug completed its phase II clinical trial successfully and is expected to enter the phase III of clinical trials in 2016.

Presently, the APD-209 is witnessing moderate rise; however, in the coming years, it will report a higher demand than FST-100. The drug, being developed by Adenovir Pharma AB, is in its second phase of clinical trial. It is likely to enter the third phase by mid-2016.

The market for FST-100 is projected to rise at a CAGR of 27.40% between 2020 and 2023 while the APD-209 market is likely to report a CAGR of 55.0% during the same period.

Enquiry for discount on this report – https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=12251

Leading Players Focus on Research Activities Thanks to Escalating Demand for Targeted Drugs for Viral Conjunctivitis

On the forefront of the global viral conjunctivitis pipeline drugs market are Panoptes Pharma GES.M.B.H., Shire Plc., Allergan Plc, Novartis AG, NovaBay Pharmaceuticals Inc., Adenovir Pharma AB, NicOx S.A., and NanoViricides Inc. As the demand for targeted drugs for viral conjunctivitis is rising, leading enterprises are focusing aggressively on research activities for the development of efficient treatments as well as diagnostic tests for viral conjunctivitis. New entrants in this market are recommended to enhance their distribution networks through strategic partnerships and alliances with local distributors.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Viral Conjunctivitis Pipeline Drugs Market to Witness a Healthy Y-o-Y Growth during 2023 here

News-ID: 966982 • Views: 180

More Releases from Transparency Market Research

Potassium Bicarbonate Market Technological breakthroughs, Value chain and stakeh …
Overview TMR’s report on the Potassium Bicarbonate Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Potassium Bicarbonate serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Potassium Bicarbonate over the forecast period. These indicators help businesses
Liquid Analytical Instruments Market Global Market Opportunity Assessment Study …
Overview TMR’s report on the Liquid Analytical Instruments Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Liquid Analytical Instruments serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Liquid Analytical Instruments over the forecast period. These
Boron Oxide Market Growth Prospects, Trends and Forecast up to 2023
Overview TMR’s report on the Boron Oxide Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Boron Oxide serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Boron Oxide over the forecast period. These indicators help businesses
Hydrochloric Acid Market to Witness a Pronounce Growth During 2016 - 2024
Overview TMR’s report on the Hydrochloric Acid Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Hydrochloric Acid serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Hydrochloric Acid over the forecast period. These indicators help businesses

All 5 Releases


More Releases for Viral

Viral Vaccines Market : Challenges and Opportunities Against Viral Diseases
Vaccines are biotic compositions. They are basically formulated from living beings that increase the resistance against a specific illness. Vaccinations that help in avoiding the occurrence of specific diseases are known as prophylactic vaccines and in other instance, the vaccines that are helpful in treating the disease are called therapeutic vaccines. A vaccine is generally produced by using a weakened or murdered type of the sickness causing microorganism. The agent
Viral Inactivation - Global Market Outlook (2017-2023)
The latest industry research report on Viral Inactivation by MRC provides a thorough analysis of the global Viral Inactivation market. The report scrutinizes the market by different segments including regions, applications, competitive landscape, etc. over the predicted time frame. This report provides 360 Degree perspective of the Viral Inactivation industry with an all-inclusive discussion of definitions, classifications, and market players in the industry chain structure. It features qualitative and quantitative
Global Viral Molecular Diagnostics Market
The Viral Molecular Diagnostics Market reportprovides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. Viral molecular diagnostic helps in
Global Viral Vector Development Service Market
Viral Vectors are the tool which is commonly used to deliver genetic material into desired cells in both in-vivo and in-vitro conditions. These viral vectors are mainly of four types namely retroviruses, lentiviruses, adenoviruses and adeno-associated viruses. These viruses are largely being used in gene therapy, which is a technique that corrects defective genes responsible for the development of the certain genetic disease. The gene therapy for such disease involves
Fzillion Goes 'VIRAL' with itsLatest Additions
Both Quality and Quantity - How Fzillion has made it possible The world is known online retailer Fzillion is now showcasing the very best of the fashion world. Just recently the store has added the newest men and kids apparel to its extensive collection. Fzillion gives you a wide range of items, ranging from high prices to low prices, from winger collections to summer collections, from everyday casual wear to the
Detecting and Preventing Viral Contamination of Food
Foodborne viral outbreaks are ever present in the media spotlight. The European Food Safety Authority (EFSA) reported that viral agents were responsible for 11.9% of the foodborne outbreaks in the European Union (EU) during 2007, coming second only to Salmonella as the most common causation agent group. Undetected food contamination Foodborne viral infections often go undetected and differ from bacterial infections in that, once present in food, viruses will neither alter the